| Primary |
| Crohn's Disease |
25.3% |
| Colitis Ulcerative |
12.3% |
| Product Used For Unknown Indication |
12.3% |
| Immunosuppression |
10.2% |
| Drug Use For Unknown Indication |
7.6% |
| Immunosuppressant Drug Therapy |
4.6% |
| Renal Transplant |
4.4% |
| Systemic Lupus Erythematosus |
3.6% |
| Rheumatoid Arthritis |
3.0% |
| Autoimmune Hepatitis |
2.7% |
| Myasthenia Gravis |
2.5% |
| Pemphigus |
2.4% |
| Prophylaxis Against Transplant Rejection |
1.8% |
| Colitis |
1.3% |
| Dermatitis Atopic |
1.1% |
| Hypertension |
1.1% |
| Dermatomyositis |
1.0% |
| Hepatitis C |
1.0% |
| Pemphigoid |
0.8% |
| Takayasu's Arteritis |
0.8% |
|
| Vomiting |
12.9% |
| Pyrexia |
9.6% |
| Weight Decreased |
9.3% |
| Pancytopenia |
7.6% |
| Sepsis |
5.3% |
| Drug Interaction |
4.8% |
| Histiocytosis Haematophagic |
4.8% |
| Thrombocytopenia |
4.8% |
| White Blood Cell Count Decreased |
4.8% |
| Acute Febrile Neutrophilic Dermatosis |
4.2% |
| Pancreatitis |
3.9% |
| Pancreatitis Acute |
3.7% |
| Squamous Cell Carcinoma |
3.7% |
| Leukopenia |
3.4% |
| Pneumonia |
3.1% |
| Tachycardia |
3.1% |
| Drug Exposure During Pregnancy |
2.8% |
| Hepatitis |
2.8% |
| Nausea |
2.8% |
| Rash |
2.8% |
|
| Secondary |
| Crohn's Disease |
21.6% |
| Immunosuppression |
12.9% |
| Product Used For Unknown Indication |
10.8% |
| Renal Transplant |
9.6% |
| Colitis Ulcerative |
7.6% |
| Drug Use For Unknown Indication |
6.5% |
| Rheumatoid Arthritis |
4.5% |
| Systemic Lupus Erythematosus |
4.4% |
| Lung Transplant |
3.3% |
| Heart Transplant |
2.3% |
| Lupus Nephritis |
2.2% |
| Psoriasis |
2.0% |
| Organ Transplant |
2.0% |
| Pemphigus |
1.8% |
| Immunosuppressant Drug Therapy |
1.8% |
| Prophylaxis Against Transplant Rejection |
1.7% |
| Liver Transplant |
1.4% |
| Anti-neutrophil Cytoplasmic Antibody Positive Vasculitis |
1.3% |
| Wegener's Granulomatosis |
1.2% |
| Vasculitis |
1.2% |
|
| Basal Cell Carcinoma |
13.2% |
| Weight Decreased |
7.0% |
| Vomiting |
6.7% |
| Pancytopenia |
6.4% |
| Thrombocytopenia |
6.4% |
| Pyrexia |
6.1% |
| Sepsis |
6.1% |
| Pneumonia |
5.0% |
| Leukopenia |
4.8% |
| Progressive Multifocal Leukoencephalopathy |
4.4% |
| Hepatosplenic T-cell Lymphoma |
4.3% |
| Squamous Cell Carcinoma |
4.0% |
| Neck Pain |
3.7% |
| Respiratory Failure |
3.5% |
| Systemic Lupus Erythematosus |
3.4% |
| Renal Failure |
3.1% |
| White Blood Cell Count Decreased |
3.1% |
| Tuberculosis |
3.0% |
| Urosepsis |
3.0% |
| Transplant Rejection |
2.9% |
|
| Concomitant |
| Crohn's Disease |
33.1% |
| Product Used For Unknown Indication |
20.6% |
| Drug Use For Unknown Indication |
11.2% |
| Colitis Ulcerative |
6.5% |
| Rheumatoid Arthritis |
6.3% |
| Renal Transplant |
3.3% |
| Hypertension |
2.5% |
| Immunosuppression |
1.9% |
| Prophylaxis |
1.8% |
| Pain |
1.7% |
| Systemic Lupus Erythematosus |
1.4% |
| Depression |
1.2% |
| Osteoporosis |
1.2% |
| Inflammatory Bowel Disease |
1.2% |
| Premedication |
1.1% |
| Idiopathic Thrombocytopenic Purpura |
1.0% |
| Immunosuppressant Drug Therapy |
1.0% |
| Prophylaxis Against Transplant Rejection |
1.0% |
| Vitamin Supplementation |
0.9% |
| Heart Transplant |
0.9% |
|
| Crohn's Disease |
14.9% |
| Vomiting |
9.4% |
| Weight Decreased |
9.3% |
| Pyrexia |
9.1% |
| Injection Site Pain |
6.4% |
| Sepsis |
5.1% |
| Urinary Tract Infection |
5.0% |
| Drug Ineffective |
4.3% |
| Pain |
4.0% |
| Pneumonia |
3.7% |
| Colitis Ulcerative |
3.4% |
| Weight Increased |
3.2% |
| Renal Failure |
3.0% |
| Intestinal Obstruction |
2.9% |
| Tremor |
2.9% |
| Incorrect Dose Administered |
2.7% |
| Pain In Extremity |
2.7% |
| Death |
2.6% |
| Urticaria |
2.6% |
| Tachycardia |
2.6% |
|
| Interacting |
| Crohn's Disease |
19.4% |
| Immunosuppression |
8.8% |
| Colitis Ulcerative |
8.2% |
| Rheumatoid Arthritis |
7.1% |
| Product Used For Unknown Indication |
6.5% |
| Pulmonary Tuberculosis |
6.5% |
| Drug Use For Unknown Indication |
4.7% |
| Renal Transplant |
4.7% |
| Hypertension |
4.1% |
| Muscular Weakness |
3.5% |
| Systemic Lupus Erythematosus |
3.5% |
| Takayasu's Arteritis |
3.5% |
| Immunosuppressant Drug Therapy |
2.9% |
| Pneumonia |
2.9% |
| Prostate Cancer |
2.9% |
| Diabetes Mellitus |
2.4% |
| Iridocyclitis |
2.4% |
| Liver Transplant |
2.4% |
| Obliterative Bronchiolitis |
1.8% |
| Osteoporosis |
1.8% |
|
| Drug Interaction |
38.3% |
| Thrombocytopenia |
10.6% |
| Haemolytic Uraemic Syndrome |
6.4% |
| Aplasia Pure Red Cell |
4.3% |
| Hodgkin's Disease Nodular Sclerosis Stage Unspecified |
4.3% |
| Pancytopenia |
4.3% |
| Ventricular Extrasystoles |
4.3% |
| Alanine Aminotransferase Increased |
2.1% |
| Blood Bilirubin Increased |
2.1% |
| Depressed Level Of Consciousness |
2.1% |
| Eye Swelling |
2.1% |
| Hepatic Encephalopathy |
2.1% |
| Hepatocellular Injury |
2.1% |
| Immunosuppressant Drug Level Decreased |
2.1% |
| Infected Bites |
2.1% |
| Influenza |
2.1% |
| Metastases To Peritoneum |
2.1% |
| Myalgia |
2.1% |
| Pain |
2.1% |
| Polymyositis |
2.1% |
|
